ArticleFrontiers in endocrinology2024

Clinicopathological characteristics, evolution, and treatment outcomes of hormone receptor-negative/HER2-low metastatic breast cancer: a pooled analysis of individual patient data from three prospective clinical trials.

Shihui Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.